IL6 and thyroid gland carcinoma: The TPC-1 cells treated with 15d-PGJ2 in the current study have shown a decrease in IL-6 expression and release associated with reduced cell proliferation, thus corroborating the aforementioned mechanism of IL-6-linked neoplastic progression in thyroid cancer cells.